Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–25 of 25 pages matching "glp-1"

⚙️ GLP-1 Signaling Pathway in NeurodegenerationKG

mechanism · 3,058 words · 303 hyp59 ana73 exp

💡 Metabolic-Energetic Restoration: GLP-1 + TFEB Activator CombinationKG

idea · 2,925 words · 21 hyp22 ana8 exp

🔬 GLP-1 ReceptorKG

protein · 2,902 words · 23 hyp8 ana11 exp

💊 GLP-1 Receptor Agonists in NeurodegenerationKG

therapeutic · 2,720 words · 282 hyp52 ana66 exp

💊 GLP-1 Receptor Agonists for Parkinson's DiseaseKG

therapeutic · 2,682 words · 27 hyp22 ana75 exp

💊 section-209-glp-1-receptor-agonists-cbs-pspKG

therapeutic · 2,422 words · 18 hyp9 ana24 exp

💊 Tirzepatide and Dual GIP/GLP-1 Agonists for NeurodegenerationKG

therapeutic · 2,057 words · 288 hyp53 ana70 exp

🏢 PD GLP-1 Receptor Agonist CompaniesKG

company · 1,932 words · 5 hyp5 ana3 exp

💊 GLP-1 Receptor Agonists for NeurodegenerationKG

therapeutic · 1,708 words · 284 hyp41 ana65 exp

🧪 GLP-1/GCG Dual Agonist LIGHT-COG (NCT07083154)KG

clinical · 1,707 words · 9 hyp4 ana13 exp

⚙️ GLP-1 Receptor Agonists for Parkinson's DiseaseKG

mechanism · 1,590 words · 26 hyp47 ana72 exp

💊 GLP-1 Receptor Agonists for Neurodegenerative DiseasesKG

therapeutic · 1,525 words · 147 hyp59 ana19 exp

💡 Intranasal Insulin and GLP-1 Combination Therapy for NeurodegenerationKG

idea · 1,511 words · 289 hyp43 ana59 exp

💊 GIP/GLP-1 Dual Agonists for Neurodegenerative DiseasesKG

therapeutic · 1,424 words · 146 hyp57 ana6 exp

💡 GLP-1 Receptor Agonist Therapy for NeurodegenerationKG

idea · 1,367 words · 282 hyp44 ana65 exp

GLP-1 Receptor Agonists — Investment Landscape AnalysisKG

investment · 1,275 words · 14 hyp15 ana16 exp

💊 GLP-1 Receptor Agonists for Neurodegenerative DiseasesKG

therapeutic · 1,073 words · 147 hyp58 ana13 exp

💊 GLP-1 and GIP Agonists for NeurodegenerationKG

therapeutic · 935 words · 283 hyp51 ana65 exp

🏢 AD Metabolic and GLP-1 Based Therapy CompaniesKG

company · 934 words · 30 hyp25 ana4 exp

GLP-1 Receptor (Glucagon-Like Peptide-1 Receptor)KG

entity · 922 words · 9 hyp7 ana26 exp

GLP-1 Receptor Agonist Responder Biology in Parkinson's DiseaseKG

gap · 875 words · 1 ana9 exp

🧫 GLP-1 Agonist Neuroprotection Mechanism in PDKG

experiment · 816 words · 3 hyp3 ana12 exp

💊 Triple Incretin Agonists (GLP-1/GIP/Glucagon) for NeurodegenerationKG

therapeutic · 741 words · 283 hyp51 ana57 exp

GLP-1 Receptor Agonist Therapeutics Investment LandscapeKG

investment · 697 words · 119 hyp53 ana33 exp

🧫 GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neuroprotection in PDKG

experiment · 666 words · 19 hyp4 ana26 exp